Laura Kenny Selected Research

Laura Kenny Research Topics

14	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2007
11	Neoplasms (Cancer) 04/2024 - 06/2012
4	Neoplasm Metastasis (Metastasis) 01/2014 - 09/2007
1	Cognitive Dysfunction 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Pressure Ulcer (Bedsore) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2019
1	Chronic Pain 01/2019
1	Pain (Aches) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Necrosis 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2016
1	Chromosomal Instability (Chromosome Stability) 01/2014

3	Aromatase InhibitorsIBA 04/2024 - 09/2017
3	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2014
3	Glyphosate (Roundup)IBA 01/2019 - 01/2018
2	Circulating Tumor DNAIBA 04/2024 - 01/2019
2	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/2018 - 09/2017
2	irosustatIBA 01/2018 - 09/2017
2	ThymidineIBA 02/2016 - 06/2012
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Cell-Free Nucleic AcidsIBA 04/2024
1	AntigensIBA 04/2024
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2023
1	eribulin FDA Link 11/2022
1	Estrogen ReceptorsIBA 07/2021
1	Capsaicin (Zostrix)FDA Link 01/2019
1	Caspase 3 (Caspase-3)IBA 12/2018
1	HerbicidesIBA 01/2018
1	Angiogenesis InhibitorsIBA 02/2016
1	Indicators and Reagents (Reagents)IBA 01/2014
1	CyclinsIBA 01/2014
1	NucleotidesIBA 01/2014
1	LigandsIBA 12/2011
1	IntegrinsIBA 12/2011
1	antibiotic K 4 (K 4)IBA 12/2011
1	AH 111585IBA 12/2011
1	Epirubicin (Ellence)FDA LinkGeneric 09/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2007
1	Fluorouracil (Carac)FDA LinkGeneric 09/2007
1	alovudineIBA 09/2007

7	Therapeutics 04/2024 - 06/2012
6	Drug Therapy (Chemotherapy) 04/2024 - 09/2007
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2021
1	Adjuvant Chemotherapy 04/2024
1	Aftercare (After-Treatment) 09/2007